Royal Medical Center Tirzepatide Review: Cost, a Contradicted Headline Price & Honest Verdict (2026)

Royal Medical Center's site returned a Cloudflare "Just a moment" challenge on this review's verification attempt, so its LegitScript status couldn't be independently checked live — though no badge is displayed anyway. Its own headline "starting at $116/month" figure directly contradicts the actual $450/month tirzepatide floor shown elsewhere on the site. Every fact here comes from the company's own published program.

A headline price that contradicts the real floor

Worth flagging directly: Royal Medical Center's own site advertises "starting at $116/month" as a headline, but the actual itemized tirzepatide pricing starts at $450/month at the 2.5 mg dose — a direct internal contradiction between the marketing headline and the real price table.

What Royal Medical Center is

Royal Medical Center is a physician-led nationwide telehealth practice, centered on hormone therapy that also offers a compounded tirzepatide weight-loss program (no semaglutide). Its founder, Dr. Dagoberto Rodriguez, MD, has an Emory residency, was former chairman at Coral Springs Medical Center, and is University of Miami faculty, with 30+ years of practice.

What Royal Medical Center costs

Tirzepatide pricing is fully itemized by dose tier: $450, $650, $800, and $1,100/month — more transparent than most "starting at" floors, once you get past the contradicted headline. All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups.

The brand-vs-compounded question

Royal Medical Center dispenses compounded tirzepatide only — no semaglutide offered. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Royal Medical Center's real strengths is a named physician founder with a strong credential background, fully itemized dose-tier pricing once you find it, all-inclusive bundling of medication, supplies, and lab monitoring, and a broad, established multi-program clinic. The trade-offs are significant: the headline "$116/month" price directly contradicts the real $450/month floor, the operating legal entity isn't disclosed, the pharmacy partner isn't named, no LegitScript badge is displayed, and states served aren't enumerated beyond a "nationwide" claim. As with any GLP-1 program, and especially one with a contradicted headline price, get your actual dose-tier price confirmed before assuming the advertised figure applies; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Royal Medical Center's named physician founder and itemized dose-tier pricing are real positives, but the site's own headline price directly contradicts the actual $450/month floor — a real inconsistency worth resolving before you commit. For a provider with a genuinely consistent headline and floor price, compare it against Rebody Health or Ondra Health. See our best tirzepatide providers ranking for the full field.